Are you Dr. Zeng?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 16 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2500 Merced St
San Leandro, CA 94577Phone+1 510-454-1000
Summary
- Dr. Li Zeng, MD is a board certified pathologist in San Leandro, California. She is currently licensed to practice medicine in California. She is affiliated with Kaiser Permanente San Leandro Medical Center and San Leandro Hospital.
Education & Training
- University of California Davis HealthResidency, Pathology-Anatomic and Clinical, 1998 - 2002
- West China University of Medical SciencesClass of 1985
Certifications & Licensure
- CA State Medical License 2000 - 2026
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 48 citationsThe Emerging Role of Glucose Metabolism in Cartilage DevelopmentJudith M. Hollander, Li Zeng
Current Osteoporosis Reports. 2019-04-01 - 50 citationsAn essential role for IGF2 in cartilage development and glucose metabolism during postnatal long bone growth.Tomoya Uchimura, Judith M. Hollander, Daisy S. Nakamura, Zhiyi Liu, Clifford J. Rosen
Development. 2017-10-01 - 3 citationsAssociations of inflammatory and metabolic biomarkers with incident erosive hand osteoarthritis in the osteoarthritis initiative cohort.Timothy E McAlindon, Jennifer L Hunnicutt, Mary B Roberts, Ida K Haugen, Lena F Schaefer
Osteoarthritis and Cartilage. 2024-05-01
Press Mentions
- Remedium Bio Announces Successful $2.3M Expanded Seed RaiseAugust 15th, 2022
- CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s DiseaseDecember 10th, 2018